Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 6 hours ago
Roche ends 2 Huntington’s disease programs, including Ionis-partnered tominersen
about 6 hours ago
Roche has halted development on two of its Huntington’s disease prospects, marking...
Illumina names new commercial, legal chiefs as sequencing business shows signs of stability
about 7 hours ago
Illumina has filled two key C-suite posts, naming Mike Sullivan as chief...
Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease
about 10 hours ago
“We were not expecting to see clinical responses so early,” Vaneet Sandhu...
Why biotech revenue projections ‘won’t look as sunny’ once Trump tax bill hits Medicaid enrollment
about 11 hours ago
Insurance coverage losses caused by the Trump administration's tax and spend law...
GSK cuts losses on $700M upfront Alzheimer’s collab with Alector following 2 clinical failures
about 13 hours ago
GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact...
FDA halts release of new drug rejection letters while working to formalize policy
1 day ago
The FDA has paused a controversial policy of releasing letters describing its...
Prime wins patent fight with Beam to continue work on AATD gene editing therapy
1 day ago
Prime Medicine has come out ahead in its patent dispute with fellow...
Satellos’ ‘intriguing’ Duchenne data raise hopes ahead of key readout
1 day ago
Satellos Bioscience has shared evidence that its Duchenne muscular dystrophy drug candidate...
Scipher picks up Chemomab’s rheumatoid arthritis drug, Nasdaq listing in all-stock merger
1 day ago
Precision immunology company Scipher Medicine will absorb Chemomab Therapeutics after having identified...
Caidya and Simbec-Orion unite in global CRO combo
1 day ago
Contract research organizations (CROs) Caidya and Simbec-Orion have united to create a...
Leo Cancer Care secures $65M series D to advance upright radiotherapy system
1 day ago
Medical technology company Leo Cancer Care closed a $65 million series D...
AstraZeneca pens $2.1B Sino deal for challenger to Merck’s COPD drug Ohtuvayre
1 day ago
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to...